Written & medically reviewed by Dr. Albana Greca, MD, MMedSc
Family Physician / General Practitioner • Founder & Lead Medical Author, Prostate Treatment Options • Last medically reviewed: September 2026
Original Question from Bruno (Millbrae, California):

I have had an enlarged prostate for several years and continue to take Flomax. I am almost 82 and remain undecided about surgery. Is TURP very risky at my age?

Quick Answer

Age 81–82 by itself does not make TURP inappropriate. Many men over 80 benefit substantially from surgery for proven benign prostate obstruction. The important questions are your overall health, frailty, heart and lung status, kidney function, blood-thinning medicines, prostate size, bladder function and why surgery is being considered.

TURP remains an established treatment, particularly for prostates roughly 30–80 mL. However, modern evidence suggests that in men over 80, HoLEP may have a lower perioperative complication burden than TURP in experienced centers, while still providing strong and durable relief.

Flomax (tamsulosin) can improve urinary symptoms, but it does not shrink the prostate or prevent future urinary retention or the need for surgery. If symptoms are controlled and there are no complications, continuing medication can be reasonable. Surgery becomes more compelling when there is refractory retention, kidney effects, recurrent infection or stones, persistent bleeding from BPH, or symptoms that remain unacceptable despite treatment.

Hello Bruno,

The safest way to answer your question is not “82 is too old” or “TURP is safe for everyone.” Chronological age is only one part of surgical risk.

What Matters More Than Age?

Before deciding on surgery, your urologist and anesthesia team should consider:

  • your level of independence and frailty;
  • heart and lung disease;
  • kidney function;
  • blood pressure;
  • diabetes if present;
  • history of stroke or heart attack;
  • anticoagulant or antiplatelet medicines;
  • cognitive status and fall risk;
  • prostate size and anatomy;
  • post-void residual urine;
  • urinary flow rate; and
  • whether your bladder muscle still contracts adequately.
A healthy, active 82-year-old may be a better surgical candidate than a frail 72-year-old with severe heart, lung or neurological disease.

When Is Surgery Actually Recommended for BPH?

Current AUA guidance recommends surgery when BPH causes:

  • refractory urinary retention;
  • kidney insufficiency caused by BPH obstruction;
  • recurrent urinary tract infections related to obstruction;
  • recurrent bladder stones;
  • recurrent gross hematuria attributed to BPH; or
  • lower urinary tract symptoms that remain unacceptable despite—or instead of—other treatment.

Current EAU guidance gives a similar framework and also includes upper urinary tract dilation from obstruction and symptoms or high residual urine that do not respond adequately to conservative or medical treatment.

Is a PVR Above 250 mL an Absolute Reason for Surgery?

No.

The old answer listed a post-void residual above 250 mL as an absolute surgical indication. Current guidance does not support one universal PVR cutoff that automatically requires surgery.

The AUA specifically cautions that an elevated PVR should not be used as the sole indication for bladder-outlet surgery.

A high residual becomes more important when it is associated with:

  • recurrent urinary retention;
  • infection;
  • kidney impairment;
  • hydronephrosis;
  • bladder stones;
  • overflow leakage; or
  • major impact on quality of life.

Does Flomax Prevent the Need for Surgery?

No.

Flomax is the brand name for tamsulosin, an alpha-1 blocker.

It relaxes smooth muscle around the prostate and bladder neck and can improve symptoms and urinary flow relatively quickly.

However, current EAU guidance states that alpha blockers do not prevent urinary retention or the eventual need for surgery.

Tamsulosin is also not necessarily “the most effective treatment” for every man. Treatment selection depends on symptom pattern, prostate size, progression risk and side-effect priorities.

See our BPH medication guide.

Could Another Medicine Be Added Before Surgery?

Possibly, depending on prostate size and current symptoms.

Finasteride or Dutasteride

If the prostate is clearly enlarged and progression risk is significant, a 5-alpha-reductase inhibitor can gradually reduce prostate size and lower the risk of future retention and BPH-related surgery.

Tadalafil

Tadalafil 5 mg daily can improve urinary symptoms and erectile function in appropriately selected men.

Bladder-Directed Medicines

If urgency and frequency are the dominant symptoms and residual urine is acceptable, an antimuscarinic or beta-3 agonist may sometimes be considered.

But if you have severe proven obstruction or repeated retention, adding more medicines may simply delay a more effective procedural solution.

How Effective Is TURP at Age 80 or Older?

TURP remains one of the standard operations for moderate-to-severe symptoms caused by benign prostate obstruction, particularly in prostates approximately 30–80 mL.

EAU evidence shows substantial improvements after TURP in:

  • maximum urine-flow rate;
  • symptom score;
  • quality of life; and
  • post-void residual.

Men over 80 can obtain meaningful urinary improvement, but older men generally have more comorbidities and a higher complication burden than younger patients.

Is TURP “Minimal Risk”?

No operation should be described that way.

TURP is performed through the urethra and does not require an external skin incision, but it is still surgery.

Potential complications include:

  • bleeding or need for transfusion;
  • infection;
  • temporary urinary retention;
  • temporary urgency or urinary leakage;
  • urethral stricture or bladder-neck narrowing;
  • retrograde/dry ejaculation;
  • less commonly erectile dysfunction;
  • fluid/electrolyte complications, particularly with older monopolar systems; and
  • anesthesia or cardiovascular complications.

Modern bipolar TURP uses saline irrigation and has a more favorable perioperative safety profile than traditional monopolar TURP while producing similar urinary outcomes.

What Does the Evidence Show Specifically in Men Over 80?

Current EAU evidence cites a retrospective comparison in patients over 80 in which TURP had a higher overall postoperative complication rate than HoLEP.

The reported figures were approximately:

  • 44.7% total postoperative complications after TURP versus 22.0% after HoLEP;
  • 9.2% versus 1.2% postoperative hematuria; and
  • 21% versus 9.8% transient urinary retention.

This does not mean TURP is unsafe for every octogenarian. It means that when both procedures are available, the choice deserves discussion rather than assuming TURP is automatically the best elderly option.

HoLEP May Be Particularly Worth Discussing

HoLEP—holmium laser enucleation of the prostate—removes the obstructing inner prostate tissue using a laser and works across a broad range of prostate sizes.

Recent studies specifically including octogenarians and nonagenarians show that men aged 80 and older can achieve substantial improvements in urinary symptoms and quality of life after HoLEP.

Older patients do have higher rates of short-term complications, emergency visits and temporary urinary leakage than younger men, but functional urinary outcomes can still be excellent.

The surgeon’s experience matters greatly. A high-volume HoLEP center may offer an excellent option, but an experienced TURP surgeon may be preferable to an inexperienced HoLEP program.

How Do Modern Options Compare?

Procedure Where it fits Advantages Important limitations
Bipolar TURP Established standard, especially ~30–80 mL prostates. Strong flow and symptom improvement; widely available. Bleeding, catheter/hospital recovery and retrograde ejaculation; octogenarians can have higher perioperative complications.
HoLEP Works across a broad range of prostate sizes. Highly effective, durable, excellent hemostasis; favorable data in older men. Requires specialized expertise; temporary leakage can be more common in very elderly patients.
GreenLight / laser vaporization Alternative for selected men, commonly 30–80 mL. Good hemostatic profile; may be useful in selected patients taking antiplatelet/anticoagulant therapy. Retreatment can be higher than with enucleation in some settings.
Aquablation Selected prostates and anatomy. Strong symptom improvement and better ejaculation preservation than TURP in trials. Still an operating-room procedure; bleeding considerations remain important.
Rezūm / UroLift Selected men prioritizing lower procedural burden or ejaculation preservation. Usually less invasive and often outpatient/office-based. Generally less improvement in obstruction and higher retreatment likelihood than tissue-removing surgery; suitability depends on anatomy and severity.
Simple prostatectomy / robotic simple prostatectomy Usually considered for very large prostates when endoscopic enucleation is unsuitable or unavailable. Very effective removal of large adenoma. More invasive than transurethral procedures; “Da Vinci” is simply a robotic platform, not a separate BPH diagnosis or universal best option.

What About TUMT, TUNA and HIFU?

I would remove them from the modern list of preferred BPH procedures.

The old answer described TUMT and TUNA as new procedures. They are now legacy technologies.

NICE specifically advises against offering TUNA, TUMT or HIFU as alternatives to established procedures such as TURP or HoLEP for voiding symptoms presumed secondary to benign prostate enlargement.

HIFU is much better known today as a focal treatment technology in selected prostate-cancer settings rather than a mainstream BPH operation.

Is “Robotic Surgery” the Newest or Safest Choice?

Not automatically.

Robotic surgery for BPH usually means robot-assisted simple prostatectomy, which is generally considered for a very large prostate when substantial adenoma removal is needed.

The Da Vinci robot is a surgical platform. It does not make a procedure inherently safer simply because a robot is involved.

For many men with moderate-sized prostates, TURP or HoLEP is considerably less invasive.

What About Sexual Side Effects?

This should be discussed before surgery rather than afterward.

TURP and HoLEP generally preserve the ability to have erections in most men, but retrograde or dry ejaculation is common.

If preserving ejaculation is important, tell the urologist before selecting the procedure because options such as UroLift, Rezūm or Aquablation may have a better chance of preserving forward ejaculation in selected men.

What Tests Should Be Done Before Deciding?

I would want to know:

  1. How severe and bothersome are your symptoms (IPSS)?
  2. What is your prostate volume?
  3. What is your post-void residual?
  4. What is your maximum urinary flow rate?
  5. Have you ever had urinary retention requiring catheterization?
  6. Do you have recurrent UTIs, stones, bleeding or kidney effects?
  7. Are you taking anticoagulants or antiplatelet medicines?
  8. Are you medically fit for anesthesia?
  9. Is there any concern that weak bladder contraction rather than obstruction is the main problem?
  10. Which procedure does your surgeon perform frequently, and what are that center’s outcomes in men over 80?

What If Your Symptoms Are Controlled With Flomax?

If you are satisfied with your urination, empty the bladder adequately and have none of the complications that make surgery advisable, there is no rule requiring surgery just because you are almost 82.

Continuing medical treatment and monitoring can be reasonable.

However, age should also not be used as a reason to postpone a needed operation until an emergency develops. If there is progressive retention, recurrent infection, kidney effects or severe symptoms, elective surgery after appropriate medical optimization may be safer than waiting for emergency catheterization or hospitalization.

My advice to Bruno:

At almost 82, I would not reject TURP simply because of your age. I would ask your urologist to estimate your individual operative risk based on frailty, cardiovascular and pulmonary health, kidney function, blood-thinning medicines and anesthesia assessment.

I would also ask for your prostate volume, urine-flow rate and post-void residual so you know whether surgery is truly necessary.

If surgery is indicated and your prostate anatomy is suitable, discuss bipolar TURP versus HoLEP rather than assuming TURP is the only option. Current evidence in men over 80 suggests HoLEP can provide excellent functional results and may have a lower perioperative complication burden in experienced centers.

If Flomax still controls your symptoms and there are no complications, continued medical treatment may remain reasonable. The best decision is the one that balances urinary benefit, procedural risk and your personal priorities.

Dr. Albana Greca, MD, MMedSc
Family Physician / General Practitioner
Founder & Lead Medical Author, Prostate Treatment Options

Medical References

European Association of Urology. 2026 Guidelines on the Management of Non-neurogenic Male Lower Urinary Tract Symptoms: patient selection, TURP, HoLEP and surgical treatment of benign prostate obstruction.

American Urological Association. Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: indications for surgery and interpretation of post-void residual.

En bloc HoLEP in octogenarians and nonagenarians. Contemporary cohort evidence on outcomes in men aged 80 years and older.

HoLEP in nonagenarians and octogenarians: impact of age and frailty. Contemporary outcome data in elderly patients.

National Institute for Health and Care Excellence. Male LUTS guideline: TUNA, TUMT and HIFU are not recommended alternatives to established surgery for BPH-related voiding LUTS.

National Institute of Diabetes and Digestive and Kidney Diseases. Enlarged Prostate (BPH): surgery, complications and recovery.

Last evidence update: September 2026.